ArticleDiabetes, obesity & metabolism2019

Evaluation of the long-term cost-effectiveness of once-weekly semaglutide versus dulaglutide for treatment of type 2 diabetes mellitus in the UK.

Adie Viljoen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.